Aktywne Wpisy
Kolorowezworki +160
Zdałem sobie sprawę, że przepisowa jazda po Polsce jest nie lada wyzwaniem. Podczas moich ostatnich wyjazdów, których trasa łącznie to ponad 2k km, postanowiłem sobie, że będę jechał w 100% zgodnie z przepisami. W przypadku ograniczenia prędkości - tempomat +7km/h bo o tyle mniej więcej zawyża mój prędkościomierz. Inni kierowcy się zachowują jak jakieś małpy - podjeżdżają pod dupę, machają łapami, migają światłami, wyprzedzają i hamują przed maską, wyprzedzają na trzeciego, wyprzedzają
stormi +6
czy jest tutaj ktos przystojni? czy jestem skazana na rozmowy z brzydalami
Cases of disease collapsed by 99%, AstraZeneca protects like Pfizer
Infections collapsed by 95% and cases of full-blown disease down by 99%. These are two of the most significant preliminary data that emerged from the first study conducted in Italy on 37,000 people who had received the vaccine from January 2 in Pescara.To explain them is one of the authors: Lamberto Manzoli, director of the Department of Medical Sciences and professor of epidemiology and public health at the University of Ferrara. “The ASL of Pescara, which had been vaccinating since January 2 – said Manzoli – said to himself: let’s see how these vaccines are working. We conducted the analysis with a little fear. We were trembling at the idea that they could not work. But with great relief the preliminary data we have observed are indeed very positive “.
“The results of the experimental studies had to be verified on the general population and that’s what we did” added Manzoli, explaining that “all three vaccines” proved to be “very effective”. The study was conducted by a group of researchers from the University of Ferrara and the Pescara ASL. Among the authors are Manzoli and on the ASL front of Pescara Antonio Caponetti, medical director, and Graziella Soldato, “who vaccinated in the field”, says Manzoli. The work has just been submitted for publication in a scientific journal and therefore has not yet passed through peer review.
What the first Italian study on vaccines says
“The data are preliminary – emphasizes the epidemiologist – and we have further analyzes in the pipeline. But in the meantime we have an average follow-up of 30 days. And we were able to examine data referring to two doses of Pfizer and Moderna and a single one of AstraZeneca, because the second doses hadn’t started yet. The results show that they are all very effective. “
How was the study conducted? “We took the vaccinated people from the province of Pescara and the entire resident adult population (just under 300 thousand people)” explains Manzoli. “At the time when we conducted the study, 62 thousand were vaccinated. Having had to exclude the vaccinated in April for the technical time required for seroconversion, the data of 37 thousand people were examined and compared with those of the unvaccinated”. Among the people subjected to shield injection – with Pfizer, Moderna and AstraZeneca – there was a clear “decline in infections and Covid disease, but also in deaths (-91%, but it is an unstable estimate). In practice, we recorded a only death “, a 96-year-old woman. The data are therefore in line with the studies carried out also abroad and, moreover, would confirm the efficacy of vaccines against the English variant, which has been dominant in Abruzzo for months (as in the rest of Italy).
AstraZeneca protects like Pfizer and Moderna
Just to mention the data relating to vaccinated with AstraZeneca “the percentage of reduction of infections, cases of illness and deaths reaches 99%”, Manzoli reports. In short, other than a series B vaccine. “Maybe this high figure will change a bit in the future, but it wouldn’t drop by much,” he says. All three vaccines, however, had “similar data, confidence intervals overlap. And I can say they go beyond the wildest expectations. Preliminary data on adverse events are also good, but we have not been able to enter them. for technical reasons. Too bad, because they could help to reassure people who need them “. Manzoli sums up what researchers have been able to observe in ‘real life’: “From an efficacy point of view, let’s see how well they work” the anti-Covid shield injections. “So, get vaccinated, if you have no other reasons that do not allow it”. The experts will now make other analyzes on the same database: “We want to understand the rate of reinfections, which is usually low, but we want to verify it. And, again, we want to investigate how many of the infected people became infected after entering the hospital.
https://www.italy24news.com/business/51255.html
#kornawirus #szczepienia #medycyna #astrazeneca